BME100 s2015:Group6 9amL1

BME 100 Spring 2015	Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help
OUR TEAM Name: Sara Belko Name: Priscilla Delgado Name: Francisco Campa File:AlaaImam.jpg Name: Alaa Imam Name: Luc Tieu LAB 1 WRITE-UP Independent and Dependent Variables Independent: dosage (milligrams) of an inflammation inducing agent (lipopolysaccharide) Dependent: amount of inflammatory protein in blood (Inflammotin) Experimental Design Groups Five Groups 1) Control (0 mg placebo sugar pill) 2) 3 mg of lipopolysaccharide 3) 5 mg of lipopolysaccharide 4) 7 mg of lipopolysaccharide 5) 10 mg of lipopolysaccharide (All groups take the pill daily before breakfast) Age "Elderly" = Ages 65 to 85 Number of subjects per group 10 people per group, 50 total Subject Selection Requirements: 1) Signs of inflammation 2) Must have inflammatory problems for at least 6 months 3) Should be off of other medicine 2 weeks prior to testing 4) Must be between the ages of 65 to 85 5) Males only 6) Moderately healthy lifestyle 7) Cannot have an allergic reaction to any drugs Sources of Error and Bias 1) Removed gender - eliminated differences in Inflammotin level between gender 2) Human error (skipping doses) - results in a lower Inflammotin level 3) Diet - can cause additional inflammation 4) Other diseases - can weaken the immune system, other medication could interfere 5) Environment (weather, humidity, etc.) - dry vs. humid could increase inflammation 6) Duration of inflammation before treatment - may decrease the effectiveness of the lipopolysaccharide 7) Severity of inflammation before treatment - may decrease the effectiveness of the lipopolysaccharide